Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP10928.RAMAhWND7hQdBE0IIL1QtpvYhJxTskrWBjTljQ69zH3SM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP10928.RAMAhWND7hQdBE0IIL1QtpvYhJxTskrWBjTljQ69zH3SM130_assertion type Assertion NP10928.RAMAhWND7hQdBE0IIL1QtpvYhJxTskrWBjTljQ69zH3SM130_head.
- NP10928.RAMAhWND7hQdBE0IIL1QtpvYhJxTskrWBjTljQ69zH3SM130_assertion description "[In vivo, treatment with troglitazone before ischemia prevented induction of Egr-1 and its target genes such as interleukin-1beta, monocyte chemotactic protein-1, and macrophage inflammatory protein-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP10928.RAMAhWND7hQdBE0IIL1QtpvYhJxTskrWBjTljQ69zH3SM130_provenance.
- NP10928.RAMAhWND7hQdBE0IIL1QtpvYhJxTskrWBjTljQ69zH3SM130_assertion evidence source_evidence_curated NP10928.RAMAhWND7hQdBE0IIL1QtpvYhJxTskrWBjTljQ69zH3SM130_provenance.
- NP10928.RAMAhWND7hQdBE0IIL1QtpvYhJxTskrWBjTljQ69zH3SM130_assertion SIO_000772 12468449 NP10928.RAMAhWND7hQdBE0IIL1QtpvYhJxTskrWBjTljQ69zH3SM130_provenance.
- NP10928.RAMAhWND7hQdBE0IIL1QtpvYhJxTskrWBjTljQ69zH3SM130_assertion wasDerivedFrom ctd_human-20130708 NP10928.RAMAhWND7hQdBE0IIL1QtpvYhJxTskrWBjTljQ69zH3SM130_provenance.
- NP10928.RAMAhWND7hQdBE0IIL1QtpvYhJxTskrWBjTljQ69zH3SM130_assertion wasGeneratedBy ECO_0000218 NP10928.RAMAhWND7hQdBE0IIL1QtpvYhJxTskrWBjTljQ69zH3SM130_provenance.